logo
3 European Stocks That May Be Undervalued In July 2025

3 European Stocks That May Be Undervalued In July 2025

Yahoo2 days ago
As the European markets show signs of resilience, with the STOXX Europe 600 Index climbing 1.32% amid easing geopolitical tensions and promises of economic stimulus, investors are keenly assessing opportunities in the region. Identifying undervalued stocks can be particularly appealing in such an environment, as these equities may offer potential for growth when market conditions stabilize further.
Name
Current Price
Fair Value (Est)
Discount (Est)
Zaptec (OB:ZAP)
NOK22.50
NOK44.90
49.9%
Qt Group Oyj (HLSE:QTCOM)
€57.55
€113.35
49.2%
Laboratorios Farmaceuticos Rovi (BME:ROVI)
€55.75
€110.26
49.4%
Ion Beam Applications (ENXTBR:IBAB)
€11.66
€22.99
49.3%
innoscripta (XTRA:1INN)
€99.30
€196.58
49.5%
Honkarakenne Oyj (HLSE:HONBS)
€2.70
€5.37
49.7%
Green Oleo (BIT:GRN)
€0.795
€1.57
49.2%
Cavotec (OM:CCC)
SEK17.00
SEK33.97
49.9%
Archicom (WSE:ARH)
PLN43.00
PLN84.73
49.2%
ABO Energy GmbH KGaA (XTRA:AB9)
€38.40
€76.54
49.8%
Click here to see the full list of 180 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Underneath we present a selection of stocks filtered out by our screen.
Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products across Spain, the European Union, OECD countries, and internationally with a market cap of €2.85 billion.
Operations: Laboratorios Farmaceuticos Rovi generates revenue through the manufacturing, selling, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and internationally.
Estimated Discount To Fair Value: 49.4%
Laboratorios Farmaceuticos Rovi is trading at €55.75, significantly below its estimated fair value of €110.26, indicating it may be undervalued based on cash flows. Analysts agree the stock price could rise by 41.8%. With earnings forecast to grow 16.5% annually—outpacing the Spanish market's 5.5%—and revenue projected to increase at 8.2%, Rovi's financial outlook remains robust despite slower-than-significant growth expectations in both earnings and revenue metrics.
Insights from our recent growth report point to a promising forecast for Laboratorios Farmaceuticos Rovi's business outlook.
Click here and access our complete balance sheet health report to understand the dynamics of Laboratorios Farmaceuticos Rovi.
Overview: Neste Oyj, with a market cap of €9.22 billion, operates in the production and distribution of renewable diesel and sustainable aviation fuel across Finland, other Nordic countries, the Baltic Rim, Europe, the United States, and internationally.
Operations: The company's revenue segments include Oil Products (€12.10 billion), Renewable Products (€7.30 billion), and Marketing & Services (€4.51 billion).
Estimated Discount To Fair Value: 19.6%
Neste Oyj is trading at €12, below its estimated fair value of €14.92, reflecting a modest undervaluation based on discounted cash flow analysis. Despite recent volatility and high debt levels, the company is expected to achieve profitability within three years with earnings projected to grow significantly annually. Recent developments in renewable fuel technology with Chevron Lummus Global highlight potential future revenue streams, although recent index exclusion may impact investor sentiment.
According our earnings growth report, there's an indication that Neste Oyj might be ready to expand.
Click here to discover the nuances of Neste Oyj with our detailed financial health report.
Overview: Andritz AG is a global provider of industrial machinery, equipment, and services across various continents including Europe, North America, South America, China, Asia, Africa, and Australia with a market cap of €5.99 billion.
Operations: The company generates revenue from four main segments: Metals (€1.78 billion), Hydro Power (€1.61 billion), Pulp & Paper (€3.27 billion), and Environment & Energy (€1.52 billion).
Estimated Discount To Fair Value: 48.3%
Andritz AG, trading at €61.5, is significantly undervalued with an estimated fair value of €118.95 based on discounted cash flow analysis. Despite a decline in first-quarter sales and net income compared to the previous year, earnings are projected to grow 11.47% annually, outpacing the Austrian market's growth rate. However, its dividend yield of 4.23% is not fully supported by free cash flows, indicating potential sustainability concerns despite strong relative value against industry peers.
Our comprehensive growth report raises the possibility that Andritz is poised for substantial financial growth.
Unlock comprehensive insights into our analysis of Andritz stock in this financial health report.
Investigate our full lineup of 180 Undervalued European Stocks Based On Cash Flows right here.
Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:ROVI HLSE:NESTE and WBAG:ANDR.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Connectez-vous pour accéder à votre portefeuille
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AirAsia's $12.3B Power Move Could Reshape Global Budget Travel
AirAsia's $12.3B Power Move Could Reshape Global Budget Travel

Yahoo

timean hour ago

  • Yahoo

AirAsia's $12.3B Power Move Could Reshape Global Budget Travel

AirAsia parent Capital A has just inked a potential $12.3 billion memorandum of understanding with Airbus (EADSY) for 50 A321XLR jetswith options for 20 more. The deal, unveiled as Malaysian Prime Minister Anwar Ibrahim wrapped up his diplomatic tour of France and Italy, is more than just a fleet refresh. It's a long-range play on global low-cost dominance. These jets, which could begin arriving by 2028, are designed to fly farther than any narrowbody aircraft, making once-uneconomical routes across Asia and beyond suddenly viable. This order allows us to have a narrowbody fleet that can cover the world, said CEO Tony Fernandes. Warning! GuruFocus has detected 6 Warning Sign with EADSY. Fernandes hinted that the A321XLR's economics could unlock expansion into India, China, and other parts of Asia-Pacificmarkets where widebodies are often too costly. But the ambitions don't stop there. AirAsia plans to launch a Gulf hub this year and is setting its sights on select European routes. The airline is also in discussions with Airbus to potentially exit its earlier A330 widebody order, signaling a full pivot toward a more nimble, fuel-efficient fleet. At the same time, Capital A is evaluating a secondary listing in Hong Kong as part of its broader strategic roadmap. Anwar's Europe visit wasn't just ceremonialit was deal-making diplomacy in motion. Alongside the commercial jet talks, Malaysia announced defense equipment purchases from Italy and France, reinforcing its security posture while boosting trade ties. In 2024, MalaysiaFrance trade hit $3.63 billion, with momentum continuing into 2025. For investors, this Airbus agreement could mark the start of a new chapter for Capital A's regional dominanceand possibly its global ambitions. This article first appeared on GuruFocus.

Nvidia (NVDA) Nears $4 Trillion as Huang Looks Beyond Chips -- Toward Robots
Nvidia (NVDA) Nears $4 Trillion as Huang Looks Beyond Chips -- Toward Robots

Yahoo

timean hour ago

  • Yahoo

Nvidia (NVDA) Nears $4 Trillion as Huang Looks Beyond Chips -- Toward Robots

Nvidia (NVDA, Financials) isn't just the chip king anymore; it's turning its gaze toward something even bigger humanoid robots. As the company brushed up against a $3.89 trillion market cap this week, CEO Jensen Huang took the stage in Paris and said it plainly; robotics, he believes, could become the largest industry in the world. Warning! GuruFocus has detected 4 Warning Signs with NVDA. That might sound ambitious; then again, so did AI a few years ago and Nvidia now dominates that space too. At the VivaTech conference, Huang introduced AEON: a full-stack humanoid robot developed with Sweden's Hexagon (HXGBY, Financials). It's not a mock-up or sci-fi concept; it's built, operational, and aiming straight for real-world deployment. Forecasts are starting to catch up. Nvidia's robotics and automotive division brought in $1.7 billion in fiscal 2024; analysts now expect that number to hit $7.55 billion by the early 2030s. If AEON gains commercial ground and it might those projections could prove too modest. Earlier this year, things looked shakier. U.S. chip export curbs to China sparked some turbulence; Nvidia stock dipped, and traders got nervous. But the pause didn't last; the stock is now up 19% for the year and once again holds the crown as the world's most valuable public company. The bigger story? That crown might soon be gilded in robotics, not just silicon. There's also seasonality working in Nvidia's favor. Historically, Q3 tends to be quiet a 4% average gain. But Q4 is where things pop; Nvidia has averaged a 23% rally in the final quarter, according to Dow Jones data. That pattern, paired with the robotics momentum, could set the stage for a breakout into even higher valuation territory. Nvidia is already in a class of its own a company that not only scaled the AI summit, but may now have the tools to build entirely new mountains. Other tech giants are maturing; Nvidia still has untouched runways. Robotics may be the next trillion-dollar catalyst and Huang knows it. As of this week, Nvidia is just $50 billion shy of Microsoft's (MSFT, Financials) all-time market cap peak. That number could fall by next week; or even tomorrow. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store